MicroRNA-103a-3p enhances sepsis-induced acute kidney injury via targeting CXCL12

References

• Wang H, Zhang P, Chen W, et al. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients’ mortality: a prospective observational study. PloS one. 2012;7(6):e38885.
   PubMed Web of Science ®Google Scholar
• Shum H-P, Kong HH-Y, Chan K-C, et al. Septic acute kidney injury in critically ill patients–a single-center study on its incidence, clinical characteristics, and outcome predictors. Ren Fail. 2016;38(5):706–716.
   PubMed Web of Science ®Google Scholar
• Tanemoto F, Mimura I. Therapies targeting epigenetic alterations in acute kidney injury-to-chronic kidney disease transition. Pharmaceutic. 2022;15(2):123.
   Web of Science ®Google Scholar
• Wang K, Ren Y, Liu Y, et al. miR-4262 promotes proliferation and invasion of human breast cancer cells through directly targeting KLF6 and KLF15. Oncol Res. 2017;25(2):277–283.
   PubMed Web of Science ®Google Scholar
• Zhou S, Xiong M, Dai G, et al. MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1. Oncol Lett. 2018;15(5):6947–6956.
   PubMed Web of Science ®Google Scholar
• Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions. Nucleic Acids Res. 2018 Jan 4;46(D1):D239–D245.
   PubMed Web of Science ®Google Scholar
• Rasmussen MH, Lyskjær I, Jersie-Christensen RR, et al. miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells. Nat Commun. 2016;7(1):12436.
   PubMedGoogle Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang S, Q-s M, et al. MicroRNAs in pathogenesis of acute kidney injury. Nephron. 2016;134(3):149–153.
   PubMed Web of Science ®Google Scholar
• Brandenburger T, Lorenzen JM. Diagnostic and therapeutic potential of microRNAs in acute kidney injury. Front Pharmacol. 2020;11:657.
   PubMed Web of Science ®Google Scholar
• Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012 Dec;97(12):E2271–6.
   PubMed Web of Science ®Google Scholar
• Pordzik J, Jakubik D, Jarosz-Popek J, et al. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review. Cardiovasc Diabetol. 2019;18(1):1–19.
   PubMed Web of Science ®Google Scholar
• Lu Q, Ma Z, Ding Y, et al. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun. 2019;10(1):1–14.
   PubMedGoogle Scholar
• Zhou YP, Xia Q. Inhibition of miR‐103a‐3p suppresses lipopolysaccharide‐induced sepsis and liver injury by regulating FBXW7 expression. Cell Biol Int. 2020;44(9):1798–1810.
   PubMed Web of Science ®Google Scholar
• García-Cuesta EM, Santiago CA, Vallejo-Díaz J, et al. The role of the CXCL12/CXCR4/ACKR3 axis in autoimmune diseases. Front Endocrinol. 2019;27(10):585.
   Web of Science ®Google Scholar
• Shen W, Weng Z, Fan M, et al. Mechanisms by which the MBD2/miR-301a-5p/CXCL12/CXCR4 pathway regulates acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2561.
   PubMed Web of Science ®Google Scholar
• Zuk A, Gershenovich M, Ivanova Y, et al. CXCR4 antagonism as a therapeutic approach to prevent acute kidney injury. Am J Physiol Renal Physiol. 2014;307(7):F783–F797.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang W, Yu G, et al. Cytoprotective effect of aquaporin 1 against lipopolysaccharide‑induced apoptosis and inflammation of renal epithelial HK‑2 cells. Exp Ther Med. 2018;15(5):4243–4252.
   PubMed Web of Science ®Google Scholar
• Sunahara S, Watanabe E, Hatano M, et al. Influence of autophagy on acute kidney injury in a murine cecal ligation and puncture sepsis model. Sci Rep. 2018;8(1):1050.
   PubMedGoogle Scholar
• Fouda E, Midan DAE, Ellaban R, et al., The diagnostic and prognostic role of MiRNA 15b and MiRNA 378a in neonatal sepsis. Biochem Biophys Rep. 2021;26:100988.
   PubMedGoogle Scholar
• Szilágyi B, Fejes Z, Pócsi M, et al. Role of sepsis modulated circulating microRNAs. Ejifcc. 2019;30(2):128.
   PubMedGoogle Scholar
• Vasilescu C, Rossi S, Shimizu M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PloS one. 2009;4(10):e7405.
   PubMed Web of Science ®Google Scholar
• Wang J-F, Yu M-L, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394(1):184–188.
   PubMed Web of Science ®Google Scholar
• Moraes CA, Santos G, D’Avila JC, et al. Activated microglia-induced deficits in excitatory synapses through IL-1β: implications for cognitive impairment in sepsis. Molec neurobio. 2015;52(1):653–663.
   PubMed Web of Science ®Google Scholar
• Morita Y, Masters EA, Schwarz EM, et al. Interleukin-27 and its diverse effects on bacterial infections. Front Immunol. 2021;12:1752.
   Web of Science ®Google Scholar
• Zhao H, Wu L, Yan G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):1–46.
   PubMed Web of Science ®Google Scholar
• Schumacher SM, Naga Prasad SV. Tumor necrosis factor-α in heart failure: an updated review. Curr Cardiol Rep. 2018;20(11):1–11.
   PubMed Web of Science ®Google Scholar
• Liu S, Wang X, She F, et al. Effects of neutrophil-to-lymphocyte ratio combined with interleukin-6 in predicting 28-day mortality in patients with sepsis. Front Immunol. 2021;12:757.
   Web of Science ®Google Scholar
• Janssens R, Struyf S, Proost P. The unique structural and functional features of CXCL12. Cell Mol Immunol. 2018;15(4):299–311.
   PubMed Web of Science ®Google Scholar
• Murad HA, Rafeeq MM, Alqurashi TM. Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate. Ann Med. 2021;53(1):1598–1612
   PubMed Web of Science ®Google Scholar
• Romoli S, Angelotti ML, Antonelli G, et al. CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism. Kidney Int. 2018;94(6):1111–1126.
   PubMed Web of Science ®Google Scholar
• Zhao L-D, Liang D, X-n W, et al. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus. Cell Mol Immunol. 2017;14(10):842–849.
   PubMed Web of Science ®Google Scholar
• Song A, Jiang A, Xiong W, et al. The role of CXCL12 in kidney diseases: a friend or foe? Kidney Dis. 2021;7(3):176–185.
   Google Scholar